NEJM Interviews

117

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their lessons for physicians.
Jun 4, 2025 – 40:04
NEJM Interview: Amar Kelkar on NIH indirect-cost coverage and U.S. medical research.
Jun 4, 2025 – 7:55
NEJM Interview: Zirui Song on the rise of concierge and direct primary care practices in the United States.
May 28, 2025 – 13:12
NEJM Interview: Alice Chen on responding to the U.S. administration’s threats to health and physicians’ values and maintaining hope in difficult times.
May 14, 2025 – 11:14
NEJM Interview: Christopher Duggan on the effects of ending U.S. foreign-assistance and global health programs.
May 7, 2025 – 7:06
NEJM Interview: Arthur Robin Williams on alcohol consumption in the United States and the effects of alcohol taxes.
Apr 30, 2025 – 9:26
NEJM Outbreaks Updates — H5N1 in Indiana
Apr 22, 2025 – 20:53
NEJM Interview: Lauren Jatt on the efficacy of twice-yearly lenacapavir for preexposure prophylaxis and its implications for the development of an HIV vaccine.
Apr 23, 2025 – 8:23
NEJM Interview: Patricia Zettler on a proposed FDA rule on nicotine yields and potential challenges moving forward.
Apr 16, 2025 – 8:11
NEJM Interview: John Patrick Co on a stipend program designed to address cost-of-living concerns for residency applicants.
Apr 9, 2025 – 5:14
NEJM Interview: Rochelle Walensky on the increased workload and emotional and financial burden associated with applying to medical school.
Mar 28, 2025 – 13:26
NEJM Interview: Erin Fuse Brown on telehealth arrangements that have prompted concerns about inappropriate prescribing and unnecessary spending.
Mar 26, 2025 – 10:10
NEJM Outbreaks Update — H5N1: A View from the States
Mar 11, 2025 – 34:39
NEJM Interview: Alex Keuroghlian on responding to policy threats to protections for transgender and nonbinary people.
Mar 12, 2025 – 9:58
NEJM Outbreaks Update — H5N1
Mar 4, 2025 – 19:05
NEJM Interview: Sara Gerke on the potential for genetic data and other personal information to be included in business transactions in the United States.
Mar 5, 2025 – 7:00
NEJM Interview: John Kelly on shifts in approaches for addressing substance use disorder.
Feb 26, 2025 – 10:41
NEJM Interview: Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs with questionable benefits.
Feb 19, 2025 – 6:55
NEJM Interview: Yashaswini Singh on the expansion of private equity investments in health care and actions to safeguard patient interests in various countries.
Feb 12, 2025 – 11:58
NEJM Interview: Joseph Ross on the newly implemented Cell and Gene Therapy Access Model.
Feb 5, 2025 – 8:19
NEJM Interview: Daniel Aaron on a Supreme Court case about e-cigarettes that could have implications for the FDA’s authority and for public health.
Jan 29, 2025 – 9:22
NEJM Interview: Craig Spencer on the need for action to address persistent inequities in global health.
Jan 22, 2025 – 17:34
NEJM Interview: Carmel Shachar on modernizing labor laws and strike regulations to support physicians, patients, and hospitals.
Jan 15, 2025 – 9:16
NEJM Interview: David Velasquez on care for older, low-income adults who can’t enroll in Medicare or Medicaid because they’re undocumented immigrants.
Jan 8, 2025 – 11:35
NEJM Interview: Joey Mattingly on providing widespread access to HCV treatment at the lowest possible price.
Jan 1, 2025 – 12:16
NEJM Interview: Lauren Schiff on the need for improved training and increased comfort in treating autistic people.
Dec 18, 2024 – 12:59
NEJM Interview: Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals.
Dec 11, 2024 – 9:12
NEJM Interview: Karen Joynt Maddox on the Transforming Episode Accountability Model recently announced by CMS.
Dec 4, 2024 – 11:16
NEJM Interview: Andrew Hantel on a source of discrimination against some patients in cancer research and care practices.
Nov 27, 2024 – 13:03
NEJM Interview: Benjamin Rome on the results of the initial round of drug-price negotiation under the Inflation Reduction Act.
Nov 20, 2024 – 9:44
NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
Nov 17, 2024 – 4:56
NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction
Nov 16, 2024 – 3:59
NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
Nov 15, 2024 – 4:29
NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
Nov 15, 2024 – 2:49
NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
Nov 15, 2024 – 3:55
NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Nov 15, 2024 – 4:15
NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Nov 15, 2024 – 3:13
NEJM Interview: Heather Hsu on an institutional conference series that provides opportunities for addressing the adverse effects of bias and medical racism.
Nov 13, 2024 – 8:27
The Marburg Virus Outbreak in Rwanda
Nov 6, 2024 – 33:27
NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities.
Nov 6, 2024 – 7:13
NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks.
Oct 30, 2024 – 13:41
NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health.
Oct 23, 2024 – 8:02
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.
Oct 16, 2024 – 21:26
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.
Oct 9, 2024 – 9:20
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.
Oct 2, 2024 – 8:47
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
Sep 15, 2024 – 2:58
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors
Sep 15, 2024 – 2:56
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer
Sep 14, 2024 – 3:23
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Sep 14, 2024 – 3:44
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Sep 14, 2024 – 3:41

Recent Reviews

Real Patriot

I wasn’t able to listen to this one

Hi there, Was anyone else able to listen to the January 26 episode, entitled, “Adressing the Omicron Variant SARS-CoV-2?” I’m a religious listener and would still like to hear this one but every time I try to open a notice pops up saying that the episode is temporarily unavailable.
Kallibri88

Very informative

Thank you for easy and convenient way to keep us updated. And share interesting cases
R. Calonge

Interview Titles

These audio interviews are great however I would like to make a observation/recommendation. My observation is that in most cases when deciding which podcast to listen to the topic is more important then the author. Because of the format of the podcast listings in iTunes, the author is always visible, but the topic is almost always truncated. Therefore, my suggestion would be to list the topic title before the author in the list of available podcasts.
Anyone of us

Thee are great!

Managing Editor Stephen Morrissey does a great job of condensing an in-depth and interesting gem of an interview into just a few minutes, perfect for your commute.
tyWellman

These are wonderful!

I've been listening to these on my commute. They're great and usually informative.